Cost-Effectiveness Of Dabigatran Etexilate Compared To Rivaroxaban For Prevention Of Stroke And Systemic Embolism In Patients With Atrial Fibrillation In China
May 1, 2018, 00:00
10.1016/j.jval.2018.04.375
https://www.valueinhealthjournal.com/article/S1098-3015(18)30675-2/fulltext
Title :
Cost-Effectiveness Of Dabigatran Etexilate Compared To Rivaroxaban For Prevention Of Stroke And Systemic Embolism In Patients With Atrial Fibrillation In China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30675-2&doi=10.1016/j.jval.2018.04.375
First page :
Section Title :
Open access? :
No
Section Order :
1232